L3VLUP
ProSign in

ALKS in the 13F filings

Alkermes PLC · CUSIP G01767105

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Jun 2024
the date the book describes
Filed
15 Aug 2024
latest of these filings; the earliest 9 Aug 2024
Managers listing it
7
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q1 2024 and Q2 2024; 5 listed it in both
Shares listed
34,139,904
combined, among listed positions
Reported value
$823m
combined, at the quarter end

Among the 94 comparable managers: 4 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing ALKS in Q2 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

7 of 7 holders

ActionFiling
Wellington Management Group LLP14,354,752$346m0.06%Trimmed-537,60814 Aug 2024 (the filing on sec.gov)
T. Rowe Price Associates Inc11,012,312$265munder 0.1%Added+2,686,05614 Aug 2024 (the filing on sec.gov)
Renaissance Technologies LLC5,483,831$132m0.22%Trimmed-403,3209 Aug 2024 (the filing on sec.gov)
Artisan Partners LP2,022,489$49m0.07%Trimmed-43,53112 Aug 2024 (the filing on sec.gov)
Woodline Partners LP1,071,071$26m0.25%Added+1,23114 Aug 2024 (the filing on sec.gov)
ExodusPoint Capital Management LP170,649$4.1munder 0.1%Newnew13 Aug 2024 (the filing on sec.gov)
PDT Partners LLC24,800$598k0.06%Newnew15 Aug 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2024 to Q2 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (2)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
8 in Q3 2024 to 9 in Q2 2026

Tracked managers listing it, at least.

0510152014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
ALKS by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20139$1.7bnn.a.n.a.
Q3 20135$1.9bnn.a.n.a.
Q4 20135$2.3bnn.a.n.a.
Q1 20145$2.9bnn.a.n.a.
Q2 20147$3.4bnn.a.n.a.
Q3 20147$3.0bnn.a.n.a.
Q4 20147$4.2bnn.a.n.a.
Q1 20158$4.5bnn.a.n.a.
Q2 20159$4.8bnn.a.n.a.
Q3 201510$4.4bnn.a.n.a.
Q4 201512$5.9bnn.a.n.a.
Q1 201610$2.6bnn.a.n.a.
Q2 20167$3.1bnn.a.n.a.
Q3 20169$3.4bnn.a.n.a.
Q4 201612$4.0bnn.a.n.a.
Q1 20179$4.1bnn.a.n.a.
Q2 201710$4.1bnn.a.n.a.
Q3 20178$3.5bnn.a.n.a.
Q4 20179$3.7bnn.a.n.a.
Q1 20187$3.9bnn.a.n.a.
Q2 20186$2.9bnn.a.n.a.
Q3 20186$3.0bnn.a.n.a.
Q4 20189$1.9bnn.a.n.a.
Q1 201911$2.3bnn.a.n.a.
Q2 201911$1.2bnn.a.n.a.
Q3 20199$1.1bnn.a.n.a.
Q4 201911$1.2bnn.a.n.a.
Q1 202014$948mn.a.n.a.
Q2 202014$1.3bnn.a.n.a.
Q3 202010$1.0bnn.a.n.a.
Q4 202013$1.2bnn.a.n.a.
Q1 202112$1.1bnn.a.n.a.
Q2 202113$1.3bnn.a.n.a.
Q3 202111$1.4bnn.a.n.a.
Q4 20219$1.1bnn.a.n.a.
Q1 202210$1.2bnn.a.n.a.
Q2 202212$903mn.a.n.a.
Q3 202210$547mn.a.n.a.
Q4 202212$831mn.a.n.a.
Q1 202312$708mn.a.n.a.
Q2 202312$703mn.a.n.a.
Q3 202312$778mn.a.n.a.
Q4 20237$754m44
Q1 20248$927m16
Q2 20247$823m43
Q3 20248$955m44
Q4 20247$801m43
Q1 20259$813m72
Q2 20259$642m36
Q3 202510$703m64
Q4 20259$566m1814
Q1 202610$436m1220
Q2 20269$1.2bn1320

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

ALKS and LLY →ALKS and JNJ →ALKS and VRTX →Choose a stock to compare with ALKS →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own ALKS, latest filings →Back to the 13F Explorer →